Hennion & Walsh Asset Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-84,458
Closed -$556K 826
2023
Q1
$556K Sell
84,458
-2,893
-3% -$19.1K 0.03% 487
2022
Q4
$508K Sell
87,351
-87,424
-50% -$547K 0.03% 499
2022
Q3
$890K Sell
174,775
-6,619
-4% -$40K 0.06% 354
2022
Q2
$805K Sell
181,394
-5,983
-3% -$41.2K 0.05% 372
2022
Q1
$1.58M Sell
187,377
-2,316
-1% -$19.7K 0.08% 255
2021
Q4
$1.82M Sell
189,693
-5,511
-3% -$64.1K 0.09% 249
2021
Q3
$2.35M Buy
195,204
+21,967
+13% +$305K 0.12% 222
2021
Q2
$2.59M Buy
173,237
+64,794
+60% +$1.02M 0.14% 203
2021
Q1
$1.79M Buy
+108,443
New +$2.05M 0.11% 252

Other funds holding MESO

Hennion & Walsh Asset Management's MESO Position: Q2 2023 in Review

Hennion & Walsh Asset Management sold out of Mesoblast (MESO) in Q2 2023, closing a stake of 84,458 shares — an estimated $556K sold.

Hennion & Walsh Asset Management first reported a position in MESO in Q1 2021 and held it in 9 quarters. The position peaked at $2.59M in Q2 2021. 43 funds tracked by Wall St. Rank hold MESO as of Q2 2023.

  • Hennion & Walsh Asset Management reported no remaining Mesoblast position as of Q2 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 84,458 Mesoblast shares in Q2 2023, an estimated $556K.
  • Hennion & Walsh Asset Management first reported a position in Mesoblast in Q1 2021 and held it in 9 quarters.
  • Hennion & Walsh Asset Management's Mesoblast position peaked at $2.59M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Mesoblast as of Q2 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.